BlackRock, Inc. - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for LIGAND PHARMACEUTICALS INC (LGND)

Filing Manager: BlackRock, Inc.
Reporting Manager: BlackRock, Inc.
Security: LIGAND PHARMACEUTICALS INC Common Stock
Symbol: LGND
Shares outstanding: 18.9M shares
Disclosed Ownership: 2.95M shares
Ownership: 15.6%
Form type: SCHEDULE 13G/A
Date filed: 2/5/2025, 01:23 PM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BlackRock, Inc.	15.6%	2.95M	2.9M	0	Spencer Fleming	Managing Director